Dominique Monnet Insider Profile
4 Followers
Dominique Monnet, former SVP & CMO at Alexion Pharmaceuticals, holds 734.92K shares in PDL BioPharma (Ticker: PDLI), holds 8.79K shares in Alexion Pharmaceuticals (Ticker: ALXN). Most recently, Dominique Monnet Sold ― shares of PDL BioPharma on Dec 17, 2020 for an estimated value of $1.30M.
Dominique Monnet's Trading History
| PDLIPDL BioPharma | Dec 17, 2020 | ― | Informative Sell | 1.30M | $1.82M | |
| ALXNAlexion Pharmaceuticals | May 22, 2015 | ― | Informative Sell | 41.57K | $1.60M |
You May Also Like
Dominique Monnet insider profile FAQ
What is the percentage of profitable transactions made by Dominique Monnet?
The percentage of profitable transactions made by Dominique Monnet is 100%.
What is the average return per transaction made by Dominique Monnet?
The average return per transaction made by Dominique Monnet is 18.50%.
What stocks does Dominique Monnet hold?
Dominique Monnet holds: ALXN, PDLI stocks.
What was Dominique Monnet’s latest transaction?
Dominique Monnet’s latest transaction was an Informative Sell of $1.30M.
What was Dominique Monnet's most profitable transaction?
Dominique Monnet’s most profitable transaction was an Informative Sell of ALXN stock on February 12, 2015. The return on the trade was 19.90%.
What is Dominique Monnet's role in Alexion Pharmaceuticals?
Dominique Monnet's role in Alexion Pharmaceuticals is SVP & CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
